cemiplimab
sanofi,regeneron
['empower-cervical 1', 'regeneron', 'sanofi']
in a mini oral session, &amp; presented the results of the empower-cervical 1 study at the ongoing 2022 conference. get more insights at: #esmo2022 #esmo #esmo22 #breakthroughs #abstracts #oncology #event #clinicaltrials 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry